1. An appreciation of Robert Turner
- Author
-
Gordon C. Weir, Stephen O'Rahilly, and David R. Matthews
- Subjects
Gerontology ,Psychoanalysis ,Biomedical Research ,Endocrinology, Diabetes and Metabolism ,Feedback control ,medicine.medical_treatment ,030209 endocrinology & metabolism ,Type 2 diabetes ,Fish insulin ,03 medical and health sciences ,0302 clinical medicine ,Diabetes mellitus ,Commentaries ,Internal Medicine ,medicine ,030212 general & internal medicine ,Insulin secretion ,business.industry ,Insulin ,History, 20th Century ,medicine.disease ,humanities ,United Kingdom ,3. Good health ,Diabetes Mellitus, Type 2 ,business ,Privilege (social inequality) ,Clearance - Abstract
Robert Turner (1938–1999) was a remarkable man. Although he is perhaps best known for the groundbreaking UK Prospective Diabetes Study (UKPDS), the breadth and depth of his contributions to diabetes research are remarkable. It is a privilege for us, just a few of his many close friends and colleagues, to be able to review his contributions as a scientist and to remember him as a unique human being. His seminal discoveries spanned three broad areas of diabetes research—namely, the physiology of insulin secretion, the etiopathogenesis of type 2 diabetes, and the clinical management of diabetes. In all of these areas, his combination of intense curiosity, intelligence, indefatigability, and passion for improved patient care led to landmark discoveries that have withstood the test of time. Robert was a medical student in Cambridge and undertook his clinical training and MD research at the Middlesex Hospital in London with Dr. John Nabarro; his thesis was entitled “Plasma Glucose Control of Insulin Secretion in Man.” The interactions of insulin and glucose occupied much of his physiological interests in those early days. His early mathematical examination of insulin delivery rate (1) was rediscovered many years later, and the concepts of feedback control were brilliantly exemplified with fish insulin, which cleared glucose but did not cross-react with insulin assays, thus allowing endogenous insulin to be assayed (2). In these early days, through exposure to scientists such as Roger Ekins, a pioneer of immunoassay, Robert was discovering that lab-based techniques were the window into complex in vivo interactions. He moved to Oxford in the early 1970s and began to develop the Diabetes Research Laboratory (DRL), which, from humble beginnings, became one of the world's leading centers for diabetes research. The DRL began to hum with activity as the charcoal separation assay developed when Robert was working with …
- Published
- 2016